194 results
Keyword aclasta Remove keyword
-
List item
Opinion/decision on a Paediatric investigation plan (PIP): Aclasta, zoledronic acid
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology, -gynacology-fertility-metabolism
PIP number: EMEA-000057-PIP01-07-M07, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Solution for infusion
Decision date: 17/01/2020, Last updated: 11/06/2020, Compliance check: XInvented name Aclasta Active substance zoledronic … Aclasta Aclasta zoledronic acid zoledronic … -
List item
Human medicine European public assessment report (EPAR): Aclasta
zoledronic acid, Osteoporosis, Osteitis Deformans, Osteoporosis, Postmenopausal
Date of authorisation: 15/04/2005, Revision: 27, Authorised, Last updated: 12/06/2020Aclasta Osteoporosis Osteitis Deformans Osteoporosis … Aclasta … summary for the public Aclasta zoledronic acid This document …